Theriva Biologics, Inc. (TOVX) Tops Q3 EPS by 23c
Tweet
Share
E-mailGet Alerts TOVX Hot Sheet
Join SI Premium – FREE
Theriva Biologics, Inc. (NYSE: TOVX) reported Q3 EPS of ($0.19), $0.23 better than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
- Xylem names Andrea van der Berg as CFO, effective Sept. 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
